JB Chemicals & Pharmaceuticals Ltd. (IN:JBCHEPHARM)
:JBCHEPHARM
JBCHEPHARM Stock Chart & Stats
₹1847.80
-₹0.05(>-0.01%)
At close: 4:00 PM EST
₹1847.80
-₹0.05(>-0.01%)
Day’s Range― - ―
52-Week Range₹1,303.00 - ₹2,195.00
Previous CloseN/A
Volume153.25K
Average Volume (3M)2.67K
Market Cap
₹313.45B
Enterprise Value₹312.88B
Total Cash (Recent Filing)₹9.01B
Total Debt (Recent Filing)₹409.10M
Price to Earnings (P/E)36.0
Beta0.50
Next Earnings
May 21, 2026EPS Estimate
11.4Next Dividend Ex-DateN/A
Dividend Yield0.86%
Share Statistics
EPS (TTM)12.70
Shares Outstanding160,558,700
10 Day Avg. Volume4,569
30 Day Avg. Volume2,671
Financial Highlights & Ratios
PEG Ratio1.96
Price to Book (P/B)7.17
Price to Sales (P/S)6.37
P/FCF Ratio30.57
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)60.63
Revenue Forecast (FY)₹47.92B
Bulls Say, Bears Say
Bulls Say
Revenue And Margin GrowthSustained revenue growth with expanding gross and net margins demonstrates scale gains and improved cost efficiency. Over 2-6 months this underpins stronger cash generation, greater reinvestment capacity into R&D and market expansion, and a firmer platform for durable profitability.
Strong Balance SheetLow leverage and a high equity share reduce financial risk and enhance flexibility for strategic initiatives. This durability supports weathering industry cycles, enables opportunistic M&A or capex funding without heavy refinancing, and preserves credit profile over the medium term.
Healthy Cash GenerationRobust operating cash conversion and rising free cash flow sustain internal funding for dividends, working capital and targeted investments. Over months this enhances financial independence, reduces external financing needs, and supports steady capital allocation to growth priorities.
Bears Say
Capex Variability RiskIrregular capital spending can create volatility in free cash flow and complicate long-term investment planning. If capex steps up unpredictably, it may temporarily constrain liquidity, delay returns on new projects, and limit consistent dividend or buyback policies over the next several quarters.
Limited Earnings TransparencyAbsence of earnings call detail or formal guidance reduces visibility into management's outlook and execution priorities. This hampers investors' ability to model forward performance, assess strategic initiatives, and monitor risks—an enduring governance/communication weakness until improved.
Competitive Generics MarketBranded generics and specialty/generic markets are structurally competitive and price sensitive, subject to regulatory pricing and tender dynamics. Sustained margin expansion is challenged by competition and policy shifts, requiring continuous product differentiation and cost control to preserve long-term profitability.
JB Chemicals & Pharmaceuticals Ltd. News
JBCHEPHARM FAQ
What was JB Chemicals & Pharmaceuticals Ltd.’s price range in the past 12 months?
JB Chemicals & Pharmaceuticals Ltd. lowest stock price was ₹1303.00 and its highest was ₹2195.00 in the past 12 months.
What is JB Chemicals & Pharmaceuticals Ltd.’s market cap?
JB Chemicals & Pharmaceuticals Ltd.’s market cap is ₹313.45B.
When is JB Chemicals & Pharmaceuticals Ltd.’s upcoming earnings report date?
JB Chemicals & Pharmaceuticals Ltd.’s upcoming earnings report date is May 21, 2026 which is in 44 days.
How were JB Chemicals & Pharmaceuticals Ltd.’s earnings last quarter?
JB Chemicals & Pharmaceuticals Ltd. released its earnings results on Jan 16, 2026. The company reported ₹12.7 earnings per share for the quarter, beating the consensus estimate of ₹12.3 by ₹0.4.
Is JB Chemicals & Pharmaceuticals Ltd. overvalued?
According to Wall Street analysts JB Chemicals & Pharmaceuticals Ltd.’s price is currently Overvalued.
Does JB Chemicals & Pharmaceuticals Ltd. pay dividends?
JB Chemicals & Pharmaceuticals Ltd. pays a Semiannually dividend of ₹7 which represents an annual dividend yield of 0.86%. See more information on JB Chemicals & Pharmaceuticals Ltd. dividends here
What is JB Chemicals & Pharmaceuticals Ltd.’s EPS estimate?
JB Chemicals & Pharmaceuticals Ltd.’s EPS estimate is 11.4.
How many shares outstanding does JB Chemicals & Pharmaceuticals Ltd. have?
JB Chemicals & Pharmaceuticals Ltd. has 160,558,700 shares outstanding.
What happened to JB Chemicals & Pharmaceuticals Ltd.’s price movement after its last earnings report?
JB Chemicals & Pharmaceuticals Ltd. reported an EPS of ₹12.7 in its last earnings report, beating expectations of ₹12.3. Following the earnings report the stock price went up 0.388%.
Which hedge fund is a major shareholder of JB Chemicals & Pharmaceuticals Ltd.?
Currently, no hedge funds are holding shares in IN:JBCHEPHARM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
JB Chemicals & Pharmaceuticals Ltd.
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets various pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients in India and internationally. Its principal products include Cilnidipine, Ranitidine, and Metronidazole. The company also provides contract manufacturing services for tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, it offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners. Further, the company provides its services in gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives, and pharmacovigilance therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is based in Mumbai, India.
Technical Analysis
Ajanta Pharma Limited
―
Emcure Pharmaceuticals Limited
―
Gland Pharma Ltd.
―
Glenmark Pharmaceuticals Limited
―
PFIZER LIMITED
―